Methylphenidate Hydrochloride Capsule, Extended Release
Product Images NDC 70010-014

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Methylphenidate Hydrochloride (NDC 70010-014). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Granules Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Methylphenidate-fig-1-jpg.jpg (Methylphenidate Fig 1 Jpg)

FDA Label Image

Methylphenidate-figur-2-jpg.jpg (Methylphenidate Figur 2 Jpg)

Methylphenidate-figur-2-jpg.jpg (Methylphenidate Figur 2 Jpg)
This looks like a table with some statistical values comparing the mean final score and mean baseline score for two treatment groups (Methylphenidate hydrochloride and Placebo). The scores seem to range from 107 to 159. There is also mention of "extended-release capsules" and "standard error of the mean". Without additional information, the purpose or context of the table cannot be determined.*
FDA Label Image

Methylphenidate-label1-jpg.jpg (Methylphenidate Label1 Jpg)

Methylphenidate-label1-jpg.jpg (Methylphenidate Label1 Jpg)
This description is for a medication called Methylphenidate Hydrochloride, which comes in extended release capsules. The specific details of the medication's dosage and administration are not available.*
FDA Label Image

Methylphenidate-label2-jpg.jpg (Methylphenidate Label2 Jpg)

FDA Label Image

Methylphenidate-label3-jpg.jpg (Methylphenidate Label3 Jpg)

FDA Label Image

Methylphenidate-label4-jpg.jpg (Methylphenidate Label4 Jpg)

Methylphenidate-label4-jpg.jpg (Methylphenidate Label4 Jpg)
This seems to be a description of a medication named "NocTIOI01401" and its proper dosage information. It appears to be extended-release capsules with the active ingredient "Methylph" (most likely methylphenidate used to treat ADHD) and the full drug name may be "Hrirenionse Extended Release Capsules (LA)". The recommended dosage and medication information are not provided.*
FDA Label Image

Methylphenidate-label5-jpg.jpg (Methylphenidate Label5 Jpg)

FDA Label Image

Methylphenidate-structure-jpg.jpg (Methylphenidate Structure Jpg)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.